Is intracytoplasmic sperm injection an add-on to conventional in vitro fertilisation for infertility without severe male factors?  

作　　者：Rong Li Rui Yang 

机构地区：[1]Center for Reproductive Medicine,Department of Obstetrics and Gynecology,Peking University Third Hospital,Beijing,People's Republic of China [2]State Key Laboratory of Female Fertility Promotion,Beijing,People's Republic of China [3]National Clinical Research Center for Obstetrics and Gynecology(Peking University Third Hospital),Beijing,People's Republic of China [4]Key Laboratory of Assisted Reproduction(Peking University),Ministry of Education,Beijing,People's Republic of China [5]Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology,Beijing,People's Republic of China

出　　处：《Gynecology and Obstetrics Clinical Medicine》2024年第2期105-107,共3页妇产科临床医学（英文）

基　　金：funded by the National Key Research and Development Program(2022YFC2702500).

摘　　要：Since the birth of the first in vitro fertilisation(IVF)baby in 1978,there have been over 12million babies born from IVF globally.l The first IVF baby in China's Mainland was born at Peking University Third Hospital in 1988;nowadays,more than 300000 IVF babies are born in China per year.Intracytoplasmic sperm injection(ICSI)was introduced in 1992 in which conventional VF(c-IVF)had failed in severe male infertile couples(figure 1).Over the past 30 years,the use of ICSI has increased and now accounts for nearly two-thirds of IVF cycles worldwide,including 70%in Europe and North America.

关 键 词：INJECTION MAINLAND INFERTILITY 

分 类 号：R714[医药卫生—妇产科学]